Henlius Schedules 19 May 2026 AGM to Endorse 2025 Financials, Auditor Re-appointments and Share Issuance Mandate

Bulletin Express04-24

Shanghai Henlius Biotech, Inc. will convene its 2026 annual general meeting (AGM) on 19 May 2026 at 3:00 p.m. in the Conference Room, 10th Floor, B8 Building, No. 188 Yizhou Road, Xuhui District, Shanghai. Shareholders of both unlisted and H shares are entitled to attend in person or vote by proxy; completed proxy forms must reach the Company’s board secretary office in Shanghai or Computershare Hong Kong Investor Services by 3:00 p.m. on 18 May 2026 (Beijing time).

The AGM agenda comprises seven ordinary and two special resolutions:

1. Approval of the Group’s 2025 annual report, Board work report, Supervisory Board report, and final accounts. 2. Adoption of the 2025 profit-distribution proposal. 3. Re-appointment of Ernst & Young Hua Ming LLP as domestic auditor and Ernst & Young as international auditor for the 2026 financial year, together with the 2025 auditor remuneration package. 4. Confirmation of 2025 remuneration for the Company’s full-time executive director. 5. Granting the Board a general mandate to (i) issue, allot and deal with additional shares and (ii) repurchase H shares, both via special resolutions.

Each share of Henlius carries a nominal value of RMB1.00 and entitles the holder to one vote on the resolutions. The meeting will proceed according to the quorum and voting thresholds stipulated by the Company’s articles and PRC corporate governance requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139268115?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-24 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139268115","market":"hk","top_or_hot":-1,"title":"Henlius Schedules 19 May 2026 AGM to Endorse 2025 Financials, Auditor Re-appointments and Share Issuance Mandate","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. will convene its 2026 annual general meeting (AGM) on 19 May 2026 at 3:00 p.m. in the Conference Room, 10th Floor, B8 Building, No. 188 Yizhou Road, Xuhui District, Shanghai. Shareholders of both unlisted and H shares are entitled to attend in person or vote by proxy; completed proxy forms must reach the Company’s board secretary office in Shanghai or Computershare Hong Kong Investor Services by 3:00 p.m. on 18 May 2026 (Beijing time).</p>\n<p>The AGM agenda comprises seven ordinary and two special resolutions:</p>\n<p>1. Approval of the Group’s 2025 annual report, Board work report, Supervisory Board report, and final accounts.  \n2. Adoption of the 2025 profit-distribution proposal.  \n3. Re-appointment of Ernst & Young Hua Ming LLP as domestic auditor and Ernst & Young as international auditor for the 2026 financial year, together with the 2025 auditor remuneration package.  \n4. Confirmation of 2025 remuneration for the Company’s full-time executive director.  \n5. Granting the Board a general mandate to (i) issue, allot and deal with additional shares and (ii) repurchase H shares, both via special resolutions.</p>\n<p>Each share of Henlius carries a nominal value of RMB1.00 and entitles the holder to one vote on the resolutions. The meeting will proceed according to the quorum and voting thresholds stipulated by the Company’s articles and PRC corporate governance requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius Schedules 19 May 2026 AGM to Endorse 2025 Financials, Auditor Re-appointments and Share Issuance Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius Schedules 19 May 2026 AGM to Endorse 2025 Financials, Auditor Re-appointments and Share Issuance Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-24 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. will convene its 2026 annual general meeting (AGM) on 19 May 2026 at 3:00 p.m. in the Conference Room, 10th Floor, B8 Building, No. 188 Yizhou Road, Xuhui District, Shanghai. Shareholders of both unlisted and H shares are entitled to attend in person or vote by proxy; completed proxy forms must reach the Company’s board secretary office in Shanghai or Computershare Hong Kong Investor Services by 3:00 p.m. on 18 May 2026 (Beijing time).</p>\n<p>The AGM agenda comprises seven ordinary and two special resolutions:</p>\n<p>1. Approval of the Group’s 2025 annual report, Board work report, Supervisory Board report, and final accounts.  \n2. Adoption of the 2025 profit-distribution proposal.  \n3. Re-appointment of Ernst & Young Hua Ming LLP as domestic auditor and Ernst & Young as international auditor for the 2026 financial year, together with the 2025 auditor remuneration package.  \n4. Confirmation of 2025 remuneration for the Company’s full-time executive director.  \n5. Granting the Board a general mandate to (i) issue, allot and deal with additional shares and (ii) repurchase H shares, both via special resolutions.</p>\n<p>Each share of Henlius carries a nominal value of RMB1.00 and entitles the holder to one vote on the resolutions. The meeting will proceed according to the quorum and voting thresholds stipulated by the Company’s articles and PRC corporate governance requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1139268115","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139268115","pubTimestamp":1777025051,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. will convene its 2026 annual general meeting (AGM) on 19 May 2026 at 3:00 p.m. in the Conference Room, 10th Floor, B8 Building, No. 188 Yizhou Road, Xuhui District,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖计划于2026年5月19日召开股东周年大会，批准2025年财务、核数师续聘及股份发行授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. will convene its 2026 annual general meeting (AGM) on 19 May 2026 at 3:00 p.m. in the Conference Room, 10th Floor, B8 Building, No. 188 Yizhou Road, Xuhui District, Shanghai. Shareholders of both unlisted and H shares are entitled to attend in person or vote by proxy; completed proxy forms must reach the Company’s board secretary office in Shanghai or Computershare Hong Kong Investor Services by 3:00 p.m. on 18 May 2026 (Beijing time).\nThe AGM agenda comprises seven ordinary and two special resolutions:\n1. Approval of the Group’s 2025 annual report, Board work report, Supervisory Board report, and final accounts.  \n2. Adoption of the 2025 profit-distribution proposal.  \n3. Re-appointment of Ernst & Young Hua Ming LLP as domestic auditor and Ernst & Young as international auditor for the 2026 financial year, together with the 2025 auditor remuneration package.  \n4. Confirmation of 2025 remuneration for the Company’s full-time executive director.  \n5. Granting the Board a general mandate to (i) issue, allot and deal with additional shares and (ii) repurchase H shares, both via special resolutions.\nEach share of Henlius carries a nominal value of RMB1.00 and entitles the holder to one vote on the resolutions. The meeting will proceed according to the quorum and voting thresholds stipulated by the Company’s articles and PRC corporate governance requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139268115","isCrawlerRequest":true}